Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RGC

Regencell Bioscience (RGC)

Regencell Bioscience Holdings Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RGC
DateTimeSourceHeadlineSymbolCompany
01/02/20246:04AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RGCRegencell Bioscience Holdings Ltd
12/15/20236:09AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RGCRegencell Bioscience Holdings Ltd
10/27/20234:15PMEdgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:RGCRegencell Bioscience Holdings Ltd
06/15/20234:01PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
06/05/20236:07AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
03/17/20236:04AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
02/28/20239:16AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
01/04/20238:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
12/22/20227:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
10/31/20224:18PMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:RGCRegencell Bioscience Holdings Ltd
09/12/20229:18AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
09/12/20229:15AMBusiness WireRegencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy TrialNASDAQ:RGCRegencell Bioscience Holdings Ltd
07/26/20228:34AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RGCRegencell Bioscience Holdings Ltd
06/07/202211:37AMValueWalkGame-Stop Or Game-On? RGC Has It All And Twice MoreNASDAQ:RGCRegencell Bioscience Holdings Ltd
06/02/20224:17PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
05/18/20228:05AMBusiness WireRegencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment PeriodNASDAQ:RGCRegencell Bioscience Holdings Ltd
05/18/20227:58AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
05/16/20228:56AMBusiness WireRegencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEONASDAQ:RGCRegencell Bioscience Holdings Ltd
05/16/20227:02AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RGCRegencell Bioscience Holdings Ltd
05/16/20227:00AMBusiness WireRegencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEONASDAQ:RGCRegencell Bioscience Holdings Ltd
05/16/20226:51AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
04/26/20228:08AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
04/04/20227:31AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RGCRegencell Bioscience Holdings Ltd
12/30/20214:06PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RGCRegencell Bioscience Holdings Ltd
12/15/20219:49AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RGCRegencell Bioscience Holdings Ltd
12/13/20218:31AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
11/17/20215:01PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
10/29/20218:32AMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:RGCRegencell Bioscience Holdings Ltd
09/07/20214:06PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
09/01/20214:21PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RGCRegencell Bioscience Holdings Ltd
 Showing the most relevant articles for your search:NASDAQ:RGC